Subjects With NSCLC With an EGFR Activating Mutation
1 competing product in clinical development for Subjects With NSCLC With an EGFR Activating Mutation.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ASP8273 | Astellas Pharma | Phase 2 | Withdrawn | 27 |